Literature DB >> 8228814

Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease.

H Deng1, R Apple, M Clare-Salzler, S Trembleau, D Mathis, L Adorini, E Sercarz.   

Abstract

How peptide-major histocompatibility complex (MHC) class II complexes are naturally generated is still unknown, but accumulating evidence suggests that unfolding proteins or long peptides can become bound to class II molecules at the dominant determinant before proteolytic cleavage. We have compared the immunogenicity of hen egg-white lysozyme (HEL) in nonobese diabetic (NOD), (NOD x BALB/c)F1, and E(d) alpha transgenic NOD mice. We find that a response to the subdominant ANOD-restricted determinant disappears upon introduction of an E(d) molecule, and is restored when scission of HEL separates this determinant from its adjoining, competitively dominant, E(d)-restricted determinant. This suggests that the E(d) molecule binds and protects its dominant determinant on a long peptide while captured neighboring determinants are lost during proteolysis. These results provide clear evidence for "determinant capture" as a mechanism of determinant selection during antigen processing and a possible explanation for MHC-protective effects in insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228814      PMCID: PMC2191262          DOI: 10.1084/jem.178.5.1675

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  32 in total

Review 1.  Determinant protection. A hypothesis for the activity of immune response genes in the processing and presentation of antigens by macrophages.

Authors:  O Werdelin
Journal:  Scand J Immunol       Date:  1986-12       Impact factor: 3.487

2.  Capacity of intact proteins to bind to MHC class II molecules.

Authors:  A Sette; L Adorini; S M Colon; S Buus; H M Grey
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

3.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

Authors:  P Panina-Bordignon; A Tan; A Termijtelen; S Demotz; G Corradin; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

4.  Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice.

Authors:  T Miyazaki; M Uno; M Uehira; H Kikutani; T Kishimoto; M Kimoto; H Nishimoto; J Miyazaki; K Yamamura
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

5.  The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.

Authors:  H Acha-Orbea; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.

Authors:  E P Reich; R S Sherwin; O Kanagawa; C A Janeway
Journal:  Nature       Date:  1989-09-28       Impact factor: 49.962

7.  Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus.

Authors:  J M Baisch; T Weeks; R Giles; M Hoover; P Stastny; J D Capra
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

8.  HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families.

Authors:  H A Erlich; A Zeidler; J Chang; S Shaw; L J Raffel; W Klitz; Y Beshkov; G Costin; S Pressman; T Bugawan
Journal:  Nat Genet       Date:  1993-04       Impact factor: 38.330

9.  Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide.

Authors:  U Hurtenbach; E Lier; L Adorini; Z A Nagy
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

10.  Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.

Authors:  L S Wicker; B J Miller; L Z Coker; S E McNally; S Scott; Y Mullen; M C Appel
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  31 in total

1.  Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition.

Authors:  Anish Suri; James J Walters; Osami Kanagawa; Michael L Gross; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

Review 2.  Impaired clearance of apoptotic cells in systemic lupus erythematosus: challenge of T and B cell tolerance.

Authors:  Susanne Kuenkele; Thomas D Beyer; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

Review 3.  Antigen presentation: lysoyme, autoimmune diabetes, and Listeria--what do they have in common?

Authors:  Emil Unanue; Craig Byersdorfer; Javier Carrero; Matteo Levisetti; Scott Lovitch; Zheng Pu; Anish Suri
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA.

Authors:  Hiroko Miyadera; Jun Ohashi; Åke Lernmark; Toshio Kitamura; Katsushi Tokunaga
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

5.  Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules.

Authors:  T P Astill; R J Ellis; S Arif; T I M Tree; M Peakman
Journal:  Diabetologia       Date:  2003-04-09       Impact factor: 10.122

Review 6.  Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism.

Authors:  Hiroko Miyadera; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2015-08-20       Impact factor: 3.172

7.  Alleviation of insulitis in NOD mice is associated with expression of transgenic MHC E molecules on primary antigen-presenting cells.

Authors:  B Pilström; J Böhme
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

8.  PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice.

Authors:  Taku Yoshida; Fang Jiang; Tasuku Honjo; Taku Okazaki
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

9.  Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.

Authors:  Daniel R Brims; Jie Qian; Irene Jarchum; Leann Mikesh; Edith Palmieri; Udupi A Ramagopal; Vladimir N Malashkevich; Rodolfo J Chaparro; Torben Lund; Masakazu Hattori; Jeffrey Shabanowitz; Donald F Hunt; Stanley G Nathenson; Steven C Almo; Teresa P Dilorenzo
Journal:  Int Immunol       Date:  2010-01-21       Impact factor: 4.823

10.  Transgenically induced GAD tolerance curtails the development of early beta-cell autoreactivities but causes the subsequent development of supernormal autoreactivities to other beta-cell antigens.

Authors:  Jide Tian; Hoa Dang; Harald von Boehmer; Elmar Jaeckel; Daniel L Kaufman
Journal:  Diabetes       Date:  2009-09-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.